CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 25,000 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 30,000 shares (grant or award)
- 4 Grant or award PRESIDENT & CSO acquired 30,000 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 60,000 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale SVP, Finance and CAO sold 2,717 shares at $13.60 ($36,957)
- 4 Open-market sale SVP, Finance and CAO sold 1,631 shares at $15.04 ($24,530)
- 4 Open-market sale Chief Medical Officer sold 3,128 shares at $15.04 ($47,045)
- 4 Open-market sale Chief Financial Officer sold 1,893 shares at $15.04 ($28,471)
- 4 Open-market sale President & CSO sold 7,179 shares at $15.04 ($107,972)
- 8-K Event Material agreement · New debt or obligation
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
Page 10 of 22 · 421 filings